Cargando…

Does efavirenz replacement improve neurological function in treated HIV infection?

OBJECTIVES: The contribution of specific antiretroviral drugs to cognitive function in HIV‐infected people remains poorly understood. Efavirenz (EFV) may plausibly cause cognitive impairment. The objective of this study was therefore to determine whether chronic EFV therapy is a modifier of neurocog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Payne, B, Chadwick, TJ, Blamire, A, Anderson, KN, Parikh, J, Qian, J, Hynes, AM, Wilkinson, J, Price, DA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600135/ https://www.ncbi.nlm.nih.gov/pubmed/28247479 http://dx.doi.org/10.1111/hiv.12503

Ejemplares similares

A Randomized Comparative Trial of Continued Abacavir/Lamivudine plus Efavirenz or Replacement with Efavirenz/Emtricitabine/Tenofovir DF in Hypercholesterolemic HIV-1 Infected Individuals
por: Moyle, Graeme J., et al.
Publicado: (2015)

Efavirenz, dysrhythmia and HIV
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Depression is associated with efavirenz-containing treatments in newly antiretroviral therapy initiated HIV patients in Ecuador
por: Checa, Alejandro, et al.
Publicado: (2020)

The Effect of Efavirenz on Estradiol Metabolism in Transgender Women
por: Leinung, Matthew C., et al.
Publicado: (2019)

Effects of vitamin D supplementation on the bone specific biomarkers in HIV infected individuals under treatment with efavirenz
por: Etminani-Esfahani, Maryam, et al.
Publicado: (2012)

Occult hepatitis B virus coinfection in HIV-positive African migrants to the UK: a point prevalence study
por: Chadwick, D, et al.
Publicado: (2014)

Comparing the efficacy of efavirenz and boosted lopinavir using viremia copy-years
por: Lima, Viviane D, et al.
Publicado: (2014)

Evaluation of an immunoassay for determination of plasma efavirenz concentrations in resource-limited settings
por: Abdissa, Alemseged, et al.
Publicado: (2014)

Variability of efavirenz plasma concentrations among pediatric HIV patients treated with efavirenz based combination antiretroviral therapy in Dar es Salaam, Tanzania
por: Sungi, Selemani Saidi, et al.
Publicado: (2018)

No evident association between efavirenz use and suicidality was identified from a disproportionality analysis using the FAERS database
por: Napoli, Andrew A, et al.
Publicado: (2014)

Serum lipid profiles among patients initiating ritonavir-boosted atazanavir versus efavirenz-based regimens
por: Ganesan, Anuradha, et al.
Publicado: (2009)

Increase in bone turnover markers in HIV patients treated with tenofovir disoproxil fumarate combined with raltegravir or efavirenz()
por: Oster, Yonatan, et al.
Publicado: (2020)

Prediction of plasma efavirenz concentrations among HIV-positive patients taking efavirenz-containing combination antiretroviral therapy
por: Huang, Sung-Hsi, et al.
Publicado: (2017)

Comparative durability of nevirapine versus efavirenz in first-line regimens during the first year of initiating antiretroviral therapy among Swaziland HIV-infected adults
por: Takuva, Simbarashe, et al.
Publicado: (2013)

HIV-Tat Exacerbates the Actions of Atazanavir, Efavirenz, and Ritonavir on Cardiac Ryanodine Receptor (RyR2)
por: Alomar, Fadhel A., et al.
Publicado: (2022)

Efavirenz: a decade of clinical experience in the treatment of HIV
por: Maggiolo, Franco
Publicado: (2009)

HIV and mental illness in Malawi and the neuropsychiatric sequelae of efavirenz
por: Drury, Andrew, et al.
Publicado: (2018)

Simultaneous Spectrophotometric Estimation of Tenofovir Disoproxil Fumarate and Lamivudine in Three Component Tablet Formulation Containing Efavirenz
por: Sharma, R., et al.
Publicado: (2010)

Outcomes in Older Versus Younger Patients Over 96 Weeks in HIV-1– Infected Patients Treated with Rilpivirine or Efavirenz in ECHO and THRIVE§
por: Ryan, Robert, et al.
Publicado: (2013)

Efavirenz use and contraceptive methods in HIV-positive women in a large urban cohort
por: Seaton, RA, et al.
Publicado: (2010)

Efavirenz and neuropsychiatric effects
por: Dheda, Mukesh
Publicado: (2017)

Predicting Efavirenz Concentrations in the Brain Tissue of HIV‐Infected Individuals and Exploring their Relationship to Neurocognitive Impairment
por: Srinivas, Nithya, et al.
Publicado: (2019)

Effectiveness of Efavirenz-Based Regimens in Young HIV-Infected Children Treated for Tuberculosis: A Treatment Option for Resource-Limited Settings
por: van Dijk, Janneke H., et al.
Publicado: (2013)

Neuropsychiatric and Neurocognitive Manifestations in HIV-Infected Children Treated With Efavirenz in South Africa—A Retrospective Case Series
por: Hammond, Charles K., et al.
Publicado: (2019)

Reversible Gynecomastia in HIV-Infected Man Treated With Triple Antiretroviral Therapy Containing Efavirenz: A Case Report
por: Essafi, Mohammed Amine, et al.
Publicado: (2022)

Antiretroviral treatment in HIV-1 infected pediatric patients: focus on efavirenz
por: Larru, Beatriz, et al.
Publicado: (2014)

Correlation of hair and plasma efavirenz concentrations in HIV-positive South Africans
por: Johnston, Jenna, et al.
Publicado: (2019)

Incidence and Determinants of Nevirapine and Efavirenz-Related Skin Rashes in West Africans: Nevirapine's Epitaph?
por: Sarfo, Fred Stephen, et al.
Publicado: (2014)

Neurodevelopmental and behavioral consequences of perinatal exposure to the HIV drug efavirenz in a rodent model
por: van de Wijer, Lisa, et al.
Publicado: (2019)

Elevated serum fibroblast growth factor 21 levels correlate with immune recovery but not mitochondrial dysfunction in HIV infection
por: Payne, Brendan AI, et al.
Publicado: (2013)

Efavirenz: History, Development and Future
por: Costa, Bárbara, et al.
Publicado: (2022)

Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic Analysis
por: Cummins, Nathan W., et al.
Publicado: (2015)

Perturbation of gut microbiota decreases susceptibility but does not modulate ongoing autoimmune neurological disease
por: Gödel, Clemens, et al.
Publicado: (2020)

Efavirenz poisoning in a 12 year old HIV negative African boy
por: Nazziwa, Rose, et al.
Publicado: (2012)

Nevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationship
por: Bhatt, Nilesh B., et al.
Publicado: (2015)

Association between exposure to Efavirenz and substrates of dysrhythmia in HIV‐infected young adults
por: Hosseini, Zahra, et al.
Publicado: (2021)

Risk of Cardiovascular Events Among Patients Initiating Efavirenz-Containing Versus Efavirenz-Free Antiretroviral Regimens
por: Rosenblatt, Lisa, et al.
Publicado: (2016)

Population Pharmacokinetics Modeling of Unbound Efavirenz, Atazanavir, and Ritonavir in HIV‐Infected Subjects With Aging Biomarkers
por: Dumond, JB, et al.
Publicado: (2016)

Formulation and optimization of liquisolid compact for enhancing dissolution properties of efavirenz by using DoE approach
por: Jaydip, Bhola, et al.
Publicado: (2020)

Role of efavirenz plasma concentrations on long-term HIV suppression and immune restoration in HIV-infected children
por: Homkham, Nontiya, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_aa32ta3fpudm1ki2gfccfoi7k1